Activist Funds Won’t Need U.S. Antitrust Nod Under New Proposal

The Federal Trade Commission on Monday proposed a rule that would exempt such investments from antitrust filing requirements in certain circumstances.

Photographer: Andrew Harrer/Bloomberg
Lock
This article is for subscribers only.

Activist investors who buy up to 10% of a company’s shares won’t need to first get U.S. antitrust approval for the purchases under a new proposal by competition regulators.

The Federal Trade Commission on Monday proposed a rule that would exempt such investments from antitrust filing requirements in certain circumstances.